Literature DB >> 9581892

Natural endogenous reverse transcription of HIV type 1.

H Zhang1, G Dornadula, R J Pomerantz.   

Abstract

Molecular mechanisms by which human lentiviruses, such as human immunodeficiency virus type 1 (HIV-1), are sexually transmitted have yet to be fully elucidated. It is now demonstrated that endogenous reverse transcription of lentiviruses can occur within the intact virion, before infection of target cells. This is a biochemically active process and is altered by the microenvironment to which HIV-1 virions are subjected. Stimulation of endogenous reverse transcription within virion particles, without nonphysiological permeabilization, has been called natural endogenous reverse transcription (NERT). This molecular mechanism has been shown to augment HIV-1 infection in initially quiescent peripheral blood mononuclear cells (PBMCs) as well as nonproliferating macrophages. As such, this process may be important in augmenting the sexual transmission of HIV-1, as genital secretions have been shown to stimulate NERT within HIV-1 virion particles. Further studies are planned to elucidate fully this initial molecular mechanism, which may be critical in understanding the sexual transmission of HIV-1 and therefore the spread of the AIDS pandemic.

Entities:  

Mesh:

Year:  1998        PMID: 9581892

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  10 in total

Review 1.  Nevirapine: a review of its use in the prevention and treatment of paediatric HIV infection.

Authors:  A Bardsley-Elliot; C M Perry
Journal:  Paediatr Drugs       Date:  2000 Sep-Oct       Impact factor: 3.022

2.  The human immunodeficiency virus type 1 TAR RNA upper stem-loop plays distinct roles in reverse transcription and RNA packaging.

Authors:  D Harrich; C W Hooker; E Parry
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

3.  Reverse transcription complex: the key player of the early phase of HIV replication.

Authors:  Sergey Iordanskiy; Michael Bukrinsky
Journal:  Future Virol       Date:  2007-01-01       Impact factor: 1.831

4.  Restoration of wild-type infectivity to human immunodeficiency virus type 1 strains lacking nef by intravirion reverse transcription.

Authors:  M Khan; M Garcia-Barrio; M D Powell
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

5.  Molecular interactions of human immunodeficiency virus type 1 with primary human oral keratinocytes.

Authors:  Edward A Acheampong; Zahida Parveen; Lois W Muthoga; Vivian Wasmuth-Peroud; Mehrnush Kalayeh; Adnan Bashir; Robert Diecidue; Muhammad Mukhtar; Roger J Pomerantz
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

6.  Complementary assays reveal a relationship between HIV-1 uncoating and reverse transcription.

Authors:  Amy E Hulme; Omar Perez; Thomas J Hope
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-31       Impact factor: 11.205

7.  Inhibition of endogenous reverse transcription of human and nonhuman primate lentiviruses: potential for development of lentivirucides.

Authors:  Elias G Argyris; Geethanjali Dornadula; Giuseppe Nunnari; Edward Acheampong; Chune Zhang; Ketti Mehlman; Roger J Pomerantz; Hui Zhang
Journal:  Virology       Date:  2006-07-21       Impact factor: 3.616

8.  Chimeric human immunodeficiency virus type 1 (HIV-1) virions containing HIV-2 or simian immunodeficiency virus Nef are resistant to cyclosporine treatment.

Authors:  Mahfuz Khan; Lingling Jin; Ming Bo Huang; Lesa Miles; Vincent C Bond; Michael D Powell
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

9.  Requirements for nucleocapsid-mediated regulation of reverse transcription during the late steps of HIV-1 assembly.

Authors:  Pierre-Jean Racine; Célia Chamontin; Hugues de Rocquigny; Serena Bernacchi; Jean-Christophe Paillart; Marylène Mougel
Journal:  Sci Rep       Date:  2016-06-07       Impact factor: 4.379

10.  Fully-spliced HIV-1 RNAs are reverse transcribed with similar efficiencies as the genomic RNA in virions and cells, but more efficiently in AZT-treated cells.

Authors:  Laurent Houzet; Zakia Morichaud; Marylène Mougel
Journal:  Retrovirology       Date:  2007-05-02       Impact factor: 4.602

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.